NICE guidance provides clear recommendations for GLP-1 use, which focus exclusively on glycaemic control in type 2 diabetes (NG28) and weight management in obesity (TA875 for semaglutide, TA664 for liraglutide)
When you feel a weaker desire to drink, it becomes much easier to manage your consumption
And once that shifted, the signals themselves started to change
Like with traditional diet and exercise, it is best not to force too much change at any given point
But insurance companies are not required to follow FDA labeling for coverage decisions
Although the drug has been promoted as safe and effective, with few long-term side effects, Ozempic has been linked to severe gastrointestinal issues, such as stomach paralysis (gastroparesis), ileus, abdominal obstructions and other adverse effects